Preparation and evaluation of inclusion complex of the lipid lowering drug lovastatin with β-cyclodextrin

Dhaka University Journal of Pharmaceutical Sciences

Volumn 6, Issue 1, 2007, Pages 25-36

  Patel, Rakesh P ^a   Patel, M M ^a  

^a GANPAT UNIVERSITY   (India)

Author keywords

In vitro dissolution studies; Inclusion complexation; Lovastatin; cyclodextrin

Indexed keywords

ANTILIPEMIC AGENT; BETA CYCLODEXTRIN; MEVINOLIN; WATER;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG MIXTURE; DRUG QUALITY; DRUG SOLUBILITY; EVAPORATION; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; STOICHIOMETRY; X RAY DIFFRACTION;

EID: 70449528133     PISSN: 18161820     EISSN: 18161839     Source Type: Journal    
DOI: 10.3329/dujps.v6i1.340     Document Type: Article

References (23)

1. Pitha, J., Milecki, J., Fales, H., Pannell, L. and Uekama, K. 1986. Hydroxypropyl-β-cyclodextrin: Preparation and characterization; Effects on solubility of drugs. Int. J. Pharm. 29, 73-82.
2. Duchêne, D. 1987. SS. Cyclodextrins and Their Industrial Uses Editions de Santé Paris, pp. 447-460.
3. Baboota, S., and Agarwal, S.P. 2003. Rofecoxib complexation with β-cyclodextrin: Influence on the anti-inflammatory and ulcerogenic activity. Die Pharmazie 58, 73-74.
4. Fernandes, C.M., Teresa, V. M. and Veiga, F.J. 2002. Physicochemical characterization and in vitro dissolution behavior of nicardipine-cyclodextrins inclusion compounds. Eur. J. Pharm. Sci. 15, 79-88.
5. Kamada, M., Hirayama, F., Udo, K., Yano, H., Arima, H., and Uekama, K. 2002. Cyclodextrin conjugate-based controlled release system: repeated- and prolonged-releases of ketoprofen after oral administration in rats. J. Control. Release. 82, 407-416.
6. Mukne, A.P. and Nagarsenker, M.S. 2004. Triamterene-β-cyclodextrin systems: Preparation, characterization and in vivo evaluation. AAPS PharmSci Tech. 5, article 19.
7. Uekama, K., and Otagiri, M. 1987. Cyclodextrins in drug carrier systems. Crit. Rev. Ther. Drug Carrier Syst. 3, 1-40.
8. Ghorab, M.K.; and Adeyeye, M.C. 2001 Elucidation of solution state complexation in wet granulated oven-dried ibuprofen and β-cyclodextrin: FT-IR and 1H-NMR studies. Pharm. Dev. Technol. 6, 315-324.
9. Veiga, F.J., Fernandes, C., Carvalho, R.A. and Geraldes, C.F. 2001. Molecular modeling and 1H-NMR: ultimate tools for the investigation of tolbutamide: β-cyclodextrin and tolbutamide: hydroxypropyl-β-cyclodextrin complexes. Chem. Pharm. Bull (Tokyo). 49, 1251-1256.
10. Bekers, O., Beijnen, J.H., Otagiri, M., Bult, A. and Underberg, W.J. 1990. Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins. J. Pharm. Biomed. Anal. 8, 671-674.
11. Uekama, K., Fujinaga, T., Hirayama, F., Otagiri, M., Yamasaki, M., Seo, A., Hashimoto, T. and Tsuruoka, M. 1983. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation. J. Pharm. Sci. 72, 1338-1341.
12. Moore, J.W. and Flanner, H. 1996. Mathematical comparison of dissolution profiles. Pharm. Tech. 20, 64-74.
13. Reppas, C. and Nicolaides, E. 2000. Analysis of drug dissolution data, In: Oral Drug Absorption and Assessment (Dressman, J.B. and Lennermas, H., Eds.) Marcel Dekker, Inc.: New York, pp. 229-254.
14. MacDonald, J.S., Gerson, R.J. Komburst, D.J., Klos, M.W., Prahalada, S., Berry, P.H., Alberts, A.W., and Bokelman, D.L. 1998. Preclinical evaluation of levastatin. Am. J. Cardiol. 62, 16J-27J.
15. Slater, E.E., and MacDonald, J.S. 1998. Mechanism of action and biological profile of HMG CoA reductase inhibitors: a new therapeutic alternative. Drugs 36 (Suppl. 3), 72-82.
16. Gerald, S.B., Dean, K.E. and Micheal J.K. 1992. Lovastatin. In: Analytical Profiles of Drug Substances and Excipients, Harry G. B. vol 21, Academic press, Inc., New York, pp. 277-315.
17. Higuchi, T. and Connors, K. 1965. Phase solubility techniques. Advances in Analytical Chemistry and Instrumention, 4, 17-123.
18. Chengsheng, L., Chenguang, L., and Kashappa Goud H. D. 2005. Enhancement of dissolution rate of valdecoxib using solid dispersions with polyethylene glycol 4000. Drug Development & Industrial Pharmacy. 1, 1-10.
19. Serajuddin A.T.M., Sheen, P.C. and Augustine, M.A. 1990. Improved dissolution of poorly water soluble drug from solid dispersion in polyethylene: polysorbate 80 mixture. J. Pharamceutical Sci. 79, 463-464.
20. Barzegar-Jalali, M., Maleki, N., Garjani, A., Khandar, A.A., Haji-Hosseinloo, M., Jabbari, R.C. and Dasmalchi, S. 2002. Enhancement of dissolution rate and anti-inflammatory effects of pitroxicam using solvent deposition technique. Drug Development & Industrial Pharmacy. 28, 691-686.
21. Tang, L., Khan, S.U. and Muhmmad, N.A. 2001. Evaluation and selection of bio-relevant disolution media for a poorly water soluble new chemical entity. Pharmaceutical Development Technology. 6, 531-540.
22. Vromans, H., Eisson, A. C. and Coenraad, F.L.. 1989. Mechanism of dissolution of drug-cyclodextrin complexes. Drug Dev. Ind. Pharm. 15, 250-255.
23. Aulton, M.E. 1988. Pharmaceutical Technology. In: Pharmaceutics: The Science of Dosage Form Design. London, UK: Churchill Livingstone; pp. 600-616.